ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1711

The Cellular Basis for Type I Interferon Production Following Ultraviolet Light Stimulated Cyclic-GMP-AMP Synthase Activation in the Skin

Jie An, Xizhang Sun, Lena Tanaka and Keith Elkon, University of Washington, Seattle, WA

Meeting: ACR Convergence 2022

Keywords: innate immunity, interferon, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: SLE – Animal Models Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: SLE patients characteristically have a type I interferon (IFN-I) signature in peripheral blood cells and this same signature is prominent in lesional and non-lesional skin. We recently demonstrated that, following a single exposure to ultraviolet light (UVB), UVB induces an IFN signature not only in the skin but also in the blood and kidneys of wild type mice. Since we observed that the IFN-I signature produced soon after UV exposure requires the DNA activated cytoplasmic sensor Cyclic-GMP-AMP (cGAMP) Synthase (cGAS), we asked which cells (skin or immune) are responsible for IFN-I production following UVB exposure?

Methods: Skin was exposed to a single dose of UVB (500 mJ/cm2) and biopsies taken before and at 24 hours after UVB exposure. mRNA expression of interferon stimulated genes (ISGs) and other inflammatory cytokines were measured by qPCR. The IFN score was derived from ISGs as previously described. Reciprocal bone marrow chimeras with either cGAS KO or Wild Type (WT) donors and recipients were generated to determine whether lack of cGAS in skin cells or immune derived (bone marrow) cells are most important in the IFN response to UV. Conditional STING KO mice were generated where STING was knocked down /out in myeloid derived cells by crossing LysM-Cre to floxed STING mice. Statistical significance between groups was determined by unpaired/paired t-test where appropriate.

Results: In 3 separate bone marrow chimera experiments with a total of 9 recipients in each group, the cGAS KO- >cGAS KO chimeras had a significantly lower IFN Score in the skin following UV compared to WT- >WT (p=0.032) (Fig.1 1A). While there was little difference in the mean IFN Score in the cGAS KO- > WT chimera, the WT- >cGAS KO chimera had a 4-fold lower IFN score (mean 4.58) compared to WT- >WT (mean 16.12). In conditional STING KO experiments, mice that lacked STING in myeloid cells, produced less IFN-I (mean IFN Score 4.29, n=10) compared to floxed controls (mean IFN Score 13.36, n=11) (Fig.1B).

Conclusion: The bone marrow chimera experiments document the requirement for cGAS in the early response to UVB. The lower IFN score in the WT- >cGAS KO compared to the reciprocal transfer suggest a requirement for cGAS in skin cells (keratinocytes or stromal cells). The lower IFN score in the LysMCre-STING floxed mice compared to control suggest myeloid cells are also required for a full IFN-I response. Whether the results can be explained by the requirement for another nucleic acid sensor such as IFI-16 or that communication between myeloid and skin cells is required for a full IFN response requires further study and will inform therapeutic approaches to prevent UV mediated exacerbations of lupus.

Supporting image 1

Figure 1: (A) Reciprocal bone marrow chimeras were performed between cGASKO and WT mice as shown and then mice exposed to UVB. IFN scores were lower in cGASKO->cGASKO and WT->cGASKO. (B) IFN scores were determined following UV exposure in mice where STING was conditionally knocked down in myeloid cells.


Disclosures: J. An, None; X. Sun, None; L. Tanaka, None; K. Elkon, None.

To cite this abstract in AMA style:

An J, Sun X, Tanaka L, Elkon K. The Cellular Basis for Type I Interferon Production Following Ultraviolet Light Stimulated Cyclic-GMP-AMP Synthase Activation in the Skin [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/the-cellular-basis-for-type-i-interferon-production-following-ultraviolet-light-stimulated-cyclic-gmp-amp-synthase-activation-in-the-skin/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-cellular-basis-for-type-i-interferon-production-following-ultraviolet-light-stimulated-cyclic-gmp-amp-synthase-activation-in-the-skin/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology